Vivesto AB

kr 7.01As of Sun 8 Nov 2026, 12:00 UTC
STO:VIVEHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (35.20%)
Div yield —
ROE (21.10%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.93
PE TTM —
TSR TTM (64.44%)
Mkt cap kr 77.61M
ROIC (13.16%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 8.27
17.96%
(68.75%)
Hold 0|6|1|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.08
0.08
0.08
0.08
21.81%
22.82%
27.30%
20.42%
Revenuekr M
3.940
3.939
4.071
4.012
6.92%
3.49%
8.21%
3.87%
Peers (US$7.846M)
Cap (US$)
PE
4.830M
0.121x
Capital
TTM
5Y
10Y
Leveragex
0.381
(0.269)
(0.242)
EBIT/Intx
0.329
0.193
0.215
Own earn%
6.69
(73.27)
(67.67)
Sh yield%
24.01
36.19
35.38
Owners
Insiders/Inst%
12.64
69.85
Short interest%
1.76
SBC / revenue%
5.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
5